发明名称 |
Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof |
摘要 |
The invention relates to compositions of DOTA derivative compounds, lanthanoid-DOTA derivative molecular complex, and lanthanoid-complex encapsulated solid lipid particles or capsules, and methods of making and using the compositions. The solid lipid particles or capsules contain micelle cores stabilized by a hyperbranched polymer shell based from a crosslinked DOTA derivative compound or crosslinked lanthanoid-DOTA derivative complex. These solid lipid particles or capsules can be used in various applications, such as contrast agents or drug delivery vehicles. |
申请公布号 |
US9579404(B2) |
申请公布日期 |
2017.02.28 |
申请号 |
US201414492749 |
申请日期 |
2014.09.22 |
申请人 |
New York University |
发明人 |
Walters Marc Anton |
分类号 |
A61K49/00;A61K49/18;A61K49/10;A61K49/12;A61K9/51;C07D257/02;C07F5/00 |
主分类号 |
A61K49/00 |
代理机构 |
LeClairRyan, a Professional Corporation |
代理人 |
LeClairRyan, a Professional Corporation |
主权项 |
1. A hyperbranched polymer nanoparticle or nanocapsule comprising:
hyperbranched polymeric unit having formula (IV):and optionally a crosslinking moiety CL,
wherein: R is H or a cation; X is O or S; n is 1-10; p is the number of the units of formula (IV) ranging from 2 to 200,000; and crosslinking moiety CL, if present, is a moiety connecting the hyperbranched polymeric units together through covalently bonding to each X of formula (IV). |
地址 |
New York NY US |